Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility Published: 12 ...
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first ...
Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Published: 2 July 2024 Touchlight to participate ...
Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template. Published: 9 ...
University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study Published: 4 April ...
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study Published: 21 November 2023 Based ...
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA Published: 24 July 2023 Curia collaborates with Touchlight to expand ...
20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project Published: 18 April 2023 Curia collaborates with Touchlight ...
Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform Published: 15 November ...
AskBio and Touchlight Restructure Joint Venture Published: 8 February 2022 Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned ...
Plasmid DNA Challenges In Advanced Therapy Manufacturing Published: 24 November 2021 Dr Tommy Duncan Introducing doggybone DNA, a synthetic antibiotic-free ...
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture Published: 29 September 2020 Curia collaborates with Touchlight to expand its mRNA ...